Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 7, 2021
Event: Entry into a Material Definitive Agreement (Share Purchase Agreement).
Key Financial Metrics
This filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the announcement of a material transaction.
Material Changes and Transaction Details
- Transaction: The Company entered into a Share Purchase Agreement (SPA) to sell its entire U.K. business operations.
- Asset Sold: All securities of AHC-WW Jersey Limited, a subsidiary operating under the Priory Group brand.
- Purchaser: RemedcoUK Limited, owned by funds managed or advised by Waterland Private Equity Fund VII.
- Completion Date: Anticipated to close on January 19, 2021, subject to mutual agreement.
- Reference: Detailed terms were previously disclosed in a Form 8-K filed on December 30, 2020.
Guidance, Outlook, and Risks
Management Commentary: The Company expects the sale to close in January 2021. The full Share Purchase Agreement is expected to be filed as an exhibit to the Annual Report on Form 10-K for the year ended December 31, 2020.
Risks and Uncertainties: The filing includes a cautionary statement regarding forward-looking statements. Actual results may differ materially due to uncertainties regarding:
- Completion of the sale pursuant to the SPA.
- The final Purchase Price.
- The Company's ability to achieve intended benefits from the sale.
- Expected costs of the transaction.
Investor Verification Checklist
- Verify the final purchase price and net proceeds once the transaction closes.
- Review the full Share Purchase Agreement when filed as an exhibit to the 2020 Form 10-K.
- Assess the impact of the divestiture on future consolidated revenue and earnings.
- Confirm the actual closing date, as it is subject to mutual agreement between the parties.